T-Cell Lymphoma FAQs
Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

Released: February 17, 2023

Expiration: February 16, 2024

Pamela B. Allen
Pamela B. Allen, MD, MSc
Steven M. Horwitz
Steven M. Horwitz, MD
Kerry Savage
Kerry Savage, MD, MSc

Activity

Progress
1
Course Completed

In this podcast episode, Steven M. Horwitz, MD; Pamela B. Allen, MD, MSc; and Kerry Savage, MD, MSc, answer questions from an audience of healthcare professionals on topics related to the management of T-cell lymphomas, including:

  • Use of brentuximab vedotin in ≤1% CD-30‒expressing lymphomas
  • Strategies with JAK inhibition and epigenetic agents
  • Allogeneic transplantation in cutaneous T-cell lymphoma